V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough
MedTech & Diagnostics

Envista Holdings Executive Compensation (FY25)

NVST · Executive and director compensation, fiscal 2025 only
Data as of September 7, 2026Latest filing (8-K): May 21, 2026
215 figures on this page: 208 cited to the filing that reported them, 7 calculated from figures it prints. See the citations
Chief executive, fiscal 2025
◇
Paul Keel
Latest say-on-pay support
=
May 19, 2026
Chief executive pay ratio
◇
To the median employee

Frequently asked questions

Answers drawn from the data on this page.
Who is Envista Holdings' chief executive and what were they paid?
Total compensation for Paul Keel, President & Chief Executive Officer, came to $10,559,567 in fiscal 2025.
What was Envista Holdings' say-on-pay result?
Shareholders supported the say-on-pay proposal with 96.5% of votes cast including abstentions in favor at the meeting held May 19, 2026 for fiscal 2025.
Which companies are in Envista Holdings' peer group?
Companies named in the disclosed peer group include Align Technology, Inc., CONMED Corporation, DENTSPLY SIRONA Inc., Enovis Corporation and Haemonetics Corporation, among others.
What is Envista Holdings' chief executive pay ratio?
For fiscal 2025, the company reported a chief executive pay ratio of 183:1, against median employee compensation of $57,572.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Paul Keel
President & Chief Executive Officer
◇—◇◇◇—◇◇
Eric Hammes
Senior Vice President and Chief Financial Officer
◇—◇◇◇—◇◇
Mark Nance
Senior Vice President, General Counsel and Secretary
◇—◇◇◇—◇◇
Veronica Acurio
President, Orthodontics
◇—◇◇◇—◇◇
Robert Befidi
President, Diagnostics
◇—◇◇◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Eric HammesPSU◇◇◇—◇—◇
Eric HammesRSU◇——◇——◇
Eric HammesOTHER◇——◇——◇
Mark NancePSU◇◇◇—◇—◇
Mark NanceRSU◇——◇——◇
Mark NanceOTHER◇——◇——◇
Paul KeelPSU◇◇◇—◇—◇
Paul KeelOPTION◇——◇—◇◇
Paul KeelRSU◇——◇——◇
Robert BefidiRSU◇——◇——◇
Robert BefidiPSU◇◇◇—◇—◇
Robert BefidiOTHER◇——◇——◇
Veronica AcurioRSU◇——◇——◇
Veronica AcurioPSU◇◇◇—◇—◇
Veronica AcurioOTHER◇——◇——◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Robert BefidiRSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇2/25/2034
RSU◇◇——
Option◇—◇2/25/2035
RSU◇◇——
Veronica AcurioRSU◇◇——
Option◇—◇2/25/2035
RSU◇◇——
RSU◇◇——
Mark NanceRSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇2/25/2034
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇2/25/2035
Option◇—◇2/25/2033
Paul KeelOption◇—◇5/25/2034
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇5/25/2034
RSU◇◇——
RSU◇◇——
Option◇—◇2/25/2035
Eric HammesOption◇—◇2/25/2035
RSU◇◇——
RSU◇◇——
RSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Scott Huennekens
Board chair
◇◇————◇
Christine Tsingos
◇◇————◇
Wendy Carruthers
◇◇————◇
Kieran T. Gallahue
◇◇————◇
Daniel A. Raskas
◇◇————◇
Barbara Hulit
◇◇————◇
Vivek Jain
◇◇————◇
J. Andrew Pierce
◇◇————◇
Paul Keel served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Board chair premium◇
Audit committee chair◇
Compensation committee chair◇
Nominating and governance chair◇
Board meeting fee◇

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Align Technology, Inc. ALGN
  • CONMED Corporation CNMD
  • DENTSPLY SIRONA Inc. XRAY
  • Enovis Corporation ENOV
  • Haemonetics Corporation HAE
  • Henry Schein, Inc. HSIC
  • Hologic, Inc. HOLX
  • ICU Medical, Inc. ICUI
  • Integer Holdings Corporation ITGR
  • Integra LifeSciences Holdings Corp. IART
  • Merit Medical Systems, Inc. MMSI
  • Revvity, Inc. RVTY
  • Teleflex Incorporated TFX
  • The Cooper Companies, Inc. COO

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025May 19, 2026=◇◇◇
2024June 10, 2025=◇◇◇
2023May 21, 2024=◇◇◇
2022May 23, 2023=◇◇◇
2021May 24, 2022=◇◇◇
2020May 25, 2021=◇◇◇
2019May 27, 2020=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
Email me this page as a cited PDF
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when Envista Holdings files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Envista Holdings disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Envista Holdings sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Enquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for a Velarion Pro seat
Full platform access for one person: every industry we cover, peer positioning, and the written analysis. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.
Join the list for Peer Group Review
Whether Envista Holdings' disclosed peer group is defensible, who names Envista Holdings back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
215 figures on this page: 208 cited to the filing that reported them, 7 calculated from figures it prints.
208 cited to the filing
7 calculated from the filing

Documents cited

  1. 0001757073-26-000043
    ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
  2. 0001757073-26-000031
    CEO Pay Ratio · Director Compensation · Director Compensation Structure · Grants of Plan-Based Awards for Fiscal 2025 · and 2 more sections
  3. 0001628280-25-031044
    ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
  4. 0001757073-24-000056
    Item 5.07 Submission of Matters to a Vote of Security Holders
  5. 0001757073-23-000051
    Item 5.07 Submission of Matters to a Vote of Security Holders
  6. 0001757073-22-000065
    Item 5.07 Submission of Matters to a Vote of Security Holders
  7. 0001757073-21-000076
    Item 5.07 Submission of Matters to a Vote of Security Holders
  8. 0001757073-20-000027
    Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Envista Holdings executive compensation, FY2025.” https://intel.velarion.ai/comp/NVST (accessed 2026).
Short form: data: Velarion
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Envista Holdings and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

MedTech & Diagnostics rankings

Chief executive pay — MedTech & DiagnosticsCEO pay ratio — MedTech & DiagnosticsSay-on-pay support — MedTech & Diagnostics

Peers Envista Holdings discloses

The companies named in NVST's own disclosed peer group.

Align Technology, Inc.CONMED CorporationDENTSPLY SIRONA Inc.Enovis CorporationHaemonetics CorporationHenry Schein, Inc.Hologic, Inc.ICU Medical, Inc.Integer Holdings CorporationIntegra LifeSciences Holdings Corp.Merit Medical Systems, Inc.Revvity, Inc.Teleflex IncorporatedThe Cooper Companies, Inc.

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  The Pay Desk · Methodology · Terms · Privacy